Literature DB >> 11425375

25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue.

V Tangpricha, J N Flanagan, L W Whitlatch, C C Tseng, T C Chen, P R Holt, M S Lipkin, M F Holick.   

Abstract

Vitamin D affects calcium metabolism and prevents proliferation of colon cells in vitro. In human beings the main circulating form of vitamin D is 25-hydroxyvitamin D; to regulate calcium homoeostasis, this form must be converted to 1alpha, 25-dihydroxyvitamin D by 1alpha-hydroxylation in the kidney with 25-hydroxyvitamin D-1alpha-hydroxylase. Cultured transformed colon cancer cells can convert 25-hydroxyvitamin D(3) to 1alpha,25-dihydroxyvitamin D(3). We identified messenger RNA (mRNA) for 25-hydroxyvitamin D-1alpha-hydroxylase in normal colon tissue and in malignant and adjacent normal colon tissue. These findings support the notion that vitamin D might have a role in cell growth regulation and cancer protection, and might be the explanation for why the risk of dying from colorectal cancer is highest in areas with the least amount of sunlight.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425375     DOI: 10.1016/S0140-6736(00)04831-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  64 in total

1.  Vitamin D insufficiency among free-living healthy young adults.

Authors:  Vin Tangpricha; Elizabeth N Pearce; Tai C Chen; Michael F Holick
Journal:  Am J Med       Date:  2002-06-01       Impact factor: 4.965

2.  Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study.

Authors:  Veronika Fedirko; Roberd M Bostick; Michael Goodman; W Dana Flanders; Myron D Gross
Journal:  Am J Epidemiol       Date:  2010-07-22       Impact factor: 4.897

Review 3.  The biology and pathology of vitamin D control in bone.

Authors:  Taison D Bell; Marie B Demay; Sherri-Ann M Burnett-Bowie
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

4.  Upregulation of 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase by butyrate in Caco-2 cells.

Authors:  Oliver Schröder; Sinan Turak; Carolin Daniel; Tanja Gaschott; Jürgen Stein
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

5.  Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer.

Authors:  Genoveva Murillo; Damien Matusiak; Richard V Benya; Rajendra G Mehta
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-24       Impact factor: 4.292

Review 6.  Resurgence of vitamin D: Old wine in new bottle.

Authors:  Raju Vaishya; Vipul Vijay; Amit Kumar Agarwal; Jabed Jahangir
Journal:  J Clin Orthop Trauma       Date:  2015-03-26

Review 7.  The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.

Authors:  Michael F Holick
Journal:  Mol Aspects Med       Date:  2008-09-02

8.  Ex vivo culture of primary human colonic tissue for studying transcriptional responses to 1α,25(OH)2 and 25(OH) vitamin D.

Authors:  Brandon Mapes; Meredith Chase; Ellie Hong; Anton Ludvik; Katy Ceryes; Yong Huang; Sonia S Kupfer
Journal:  Physiol Genomics       Date:  2014-02-18       Impact factor: 3.107

9.  Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy.

Authors:  Katie N Evans; Harris Taylor; Daniel Zehnder; Mark D Kilby; Judith N Bulmer; Farah Shah; John S Adams; Martin Hewison
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

10.  Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense.

Authors:  Sif Hansdottir; Martha M Monick; Sara L Hinde; Nina Lovan; Dwight C Look; Gary W Hunninghake
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.